Search Results
Baxter Recognized as One of Working Mother's 2018 '100 Best Companies'
Baxter International Inc. (NYSE: BAX), a leading global medical products company, today announced that it has been named to Working Mother magazine’s 2018 ‘100 Best Companies’ list. Baxter was honored for providing progressive employee programs and benefits that support career advancement, workplace flexibility, child care and employee wellness.
Baxter to Host Third Quarter 2018 Financial Results Conference Call for Investors
Baxter International Inc. (NYSE: BAX), a leading global medical products company, will host a conference call to discuss its third quarter 2018 financial results on Wednesday, October 31, 2018, at 7:30 a.m. Central Time. To access the call, dial (844) 886-1929 (domestic) or (225) 239-4663 (international). Please dial into the call at least ten minutes prior to the start for the operator to connect you. The Conference ID is 9895268.
Baxter Recognized as a Best Employer in the Asia Pacific Region by Aon
Baxter International Inc. (Baxter), a leading global medical products company, today announced it has been named Aon Best Employer, Asia Pacific (APAC).
Baxter Named to Dow Jones Sustainability Index for 19th Consecutive Year, Recognized for its Dedication to Corporate Responsibility
Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that it has been named to the Dow Jones Sustainability World Index (DJSI World Index) and the Dow Jones Sustainability North America Index (DJSI North America) for the 19th consecutive year.
Baxter Announces U.S. FDA Clearance of New Bone Graft Substitute, Actifuse Flow
Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced U.S. Food and Drug Administration (FDA) clearance of Actifuse Flow Bone Graft Substitute for use in a variety of orthopedic surgical procedures.
Baxter Unveils Olimel 7.6% High Protein Nutrition Formulation at the 2018 ESPEN Congress
Baxter International Inc.
Baxter Reports Second-Quarter 2018 Results and Increases Earnings Outlook for Full-Year 2018
Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported results for the second quarter of 2018 and increased its full-year 2018 earnings guidance.
Baxter Declares Quarterly Dividend
Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that its Board of Directors has declared a quarterly cash dividend of $0.19 per share of common stock. The dividend is payable on October 1, 2018, to stockholders of record as of August 31, 2018. The indicated annual dividend rate is $0.76 per share of common stock.
Baxter Releases 2017 Corporate Responsibility Report and Reinforces its Commitment to Enriching Communities Around the World
Baxter International Inc. (NYSE:BAX), a leading global medical products company, today released its 2017 Corporate Responsibility Report, highlighting its efforts to create lasting social, economic and environmental value in the communities the company serves around the world.
Baxter Unveiled Updates to SHARESOURCE Remote Patient Management Platform for Home Dialysis Patients at ERA-EDTA 2018
Baxter International Inc. (NYSE: BAX), a global innovator in renal care, announced the availability of two program updates for its SHARESOURCE remote patient management platform to support greater accessibility and efficiencies in remotely viewing patient data.